IRIDEX Corporation (IRIX)

Last Closing Price: 1.06 (2026-04-17)

Company Description

IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $52.67M
Net Income (Most Recent Fiscal Year) $-4.44M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 0.35
Price to Book Ratio (Most Recent Quarterly Book Value per Share) --
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -8.32%
Net Margin (Trailing 12 Months) -8.42%
Return on Equity (Trailing 12 Months) -1204.74%
Return on Assets (Trailing 12 Months) -14.39%
Current Ratio (Most Recent Fiscal Quarter) 1.91
Quick Ratio (Most Recent Fiscal Quarter) 1.32
Debt to Common Equity (Most Recent Fiscal Quarter) --
Inventory Turnover (Trailing 12 Months) 3.96
Book Value per Share (Most Recent Fiscal Quarter) $-0.06
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) $-0.26
Stock
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Common Shares Outstanding 17.31M
Free Float 16.03M
Market Capitalization $18.35M
Average Volume (Last 20 Days) 0.68M
Beta (Past 60 Months) 0.75
Percentage Held By Insiders (Latest Annual Proxy Report) 7.40%
Percentage Held By Institutions (Latest 13F Reports) 20.10%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%